Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells. by Nesrin Sabha (127278)

“…(C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”

MS diet decreases production of pro-inflammatory cytokines in stimulated T cells. by Colin Delaney (380939)

Inhibition of AhR signaling decreases growth of prostate cancer cells. by Oliver Richmond (585233)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

“…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H₂O₂ for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”

Ang 1–7 decreased Ang II-stimulated ER stress. by Dharmani Murugan (841819)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

Melatonin decreases the viability of BeWo cells under hypoxia/reoxygenation. by Lucas Sagrillo-Fagundes (6194843)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

Increase in the total probability of reward delivery decreases the reaction time of mice. by Junior Samuel López-Yépez (11565550)

Oligomycin decreases proteasome inhibition-induced cell death in the presence of Ade. by Shujue Li (466324)

L-NNA treatment decreases tumor blood flow and increases hypoxia. by Robert J. G. Cardnell (350872)

“…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”

Inhibition of <i>T. cruzi</i> Ecto-ATPDases decreased virulence to mouse. by Ramon F. Santos (374136)

ADAR2 expression is decreased in the islets of JNK1 knockout mice. by Liu Yang (23752)

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

SH-11052 decreases the expression of NF-κB target genes. by Halesha D. Basavarajappa (534825)

“…(C) qRT-PCR using TaqMan probes showed that mRNA levels of NF-κB target genes <i>IL8</i> (interleukin-8) (<i>left panel</i>), <i>CCL2</i> (MCP-1) and <i>PTGS2</i> (COX2) (<i>right panel</i>), all induced by TNF-α, were decreased in the presence of <b>2</b> in a dose dependent manner. …”

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

Combination of MK-2206 and R5020 significantly decreases cell viability. by Alok Pant (314711)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

Anti-AT prophylaxis decreases lesion size in <i>S. aureus</i> dermonecrosis. by Christine Tkaczyk (465528)